{"title":"Integrated multi-omics atlas reveals PTM-driven signaling and immunologic remodeling in a mouse model of age-related subclinical hypothyroidism.","authors":"Kun Xu, Qing Zhou","doi":"10.62347/PQYE9899","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Age-related subclinical hypothyroidism (AR-SCH) profoundly impairs thyroid structural and functional integrity in the elderly, yet the systemic molecular architecture driving AR-SCH pathogenesis remains poorly understood. This study aimed to construct a comprehensive multi-omic atlas of the AR-SCH mouse thyroid.</p><p><strong>Methods: </strong>Global proteomics, site-specific N-glycoproteomics, and phosphoproteomics were integrated to profile thyroid tissues from AR-SCH and control mice.</p><p><strong>Results: </strong>In total, 6,666 proteins, 2,476 site-specific N-glycans, and 11,929 phosphorylation sites were identified. Global proteomics revealed a widespread reduction of functional proteins (81.7% downregulated), primarily associated with cytoskeletal structural remodeling and tissue degeneration under AR-SCH conditions. N-glycoproteomics identified altered fucosylation and reduced N-glycosylation associated with extracellular-matrix organization and local immune-related processes. Furthermore, an extensive hypophosphorylation trend (91.53% downregulated sites) was associated with suppression of intracellular signaling cascades, possibly involving autophagic clearance and perturbed apoptotic homeostasis.</p><p><strong>Conclusion: </strong>Multi-omics integration suggests an interconnected network as a convergent hallmark of AR-SCH progression, characterized by cytoskeletal reconfiguration, immune regulation shifts, and signaling attenuation that synergistically contribute to systemic thyroid decline, offering a therapeutic window for preserving endocrine homeostasis.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 8","pages":"7075-7091"},"PeriodicalIF":1.8000,"publicationDate":"2026-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13590991/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of translational research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/PQYE9899","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Age-related subclinical hypothyroidism (AR-SCH) profoundly impairs thyroid structural and functional integrity in the elderly, yet the systemic molecular architecture driving AR-SCH pathogenesis remains poorly understood. This study aimed to construct a comprehensive multi-omic atlas of the AR-SCH mouse thyroid.
Methods: Global proteomics, site-specific N-glycoproteomics, and phosphoproteomics were integrated to profile thyroid tissues from AR-SCH and control mice.
Results: In total, 6,666 proteins, 2,476 site-specific N-glycans, and 11,929 phosphorylation sites were identified. Global proteomics revealed a widespread reduction of functional proteins (81.7% downregulated), primarily associated with cytoskeletal structural remodeling and tissue degeneration under AR-SCH conditions. N-glycoproteomics identified altered fucosylation and reduced N-glycosylation associated with extracellular-matrix organization and local immune-related processes. Furthermore, an extensive hypophosphorylation trend (91.53% downregulated sites) was associated with suppression of intracellular signaling cascades, possibly involving autophagic clearance and perturbed apoptotic homeostasis.
Conclusion: Multi-omics integration suggests an interconnected network as a convergent hallmark of AR-SCH progression, characterized by cytoskeletal reconfiguration, immune regulation shifts, and signaling attenuation that synergistically contribute to systemic thyroid decline, offering a therapeutic window for preserving endocrine homeostasis.